<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00696033</url>
  </required_header>
  <id_info>
    <org_study_id>3777</org_study_id>
    <nct_id>NCT00696033</nct_id>
  </id_info>
  <brief_title>Exploring the Effects of Diazepam and Lorazepam</brief_title>
  <acronym>ibid</acronym>
  <official_title>Exploring the Effects of Diazepam and Lorazepam on the Neural Correlates of Perceptual Priming and Explicit Memory in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims :

        -  exploring lorazepam (0.038 mg/kg) effects, after a single oral intake, in healthy
           volunteers, on the neural correlates of encoding and retrieval of information during a
           word-stem completion task (implicit memory), using fMRI

        -  comparing lorazepam effects to diazepam (0.3 mg/kg)effects

        -  exploring benzodiazepines effects, after a single oral intake, on the neural correlates
           of successful encoding of information within explicit memory using fMRI

      Hypothesis :

        -  both diazepam and lorazepam will impair explicit memory performance, but lorazepam only
           will impair perceptual priming

        -  lorazepam and diazepam will modify the normal correlates of information encoding within
           explicit memory

        -  lorazepam only will alter the neural correlates of perceptual priming
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exploring lorazepam (0.038 mg/kg) effects, after a single oral intake, in healthy volunteers, on the neural correlates of encoding and retrieval of information during a word-stem completion task (implicit memory), using fMRI</measure>
    <time_frame>After a single oral intake</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparing lorazepam effects to diazepam (0.3 mg/kg)effects</measure>
    <time_frame>After a single oral intake</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exploring benzodiazepines effects, after a single oral intake, on the neural correlates of successful encoding of information within explicit memory using fMRI</measure>
    <time_frame>After single oral intake</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral Lorazepam</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral Diazepam</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diazepam</intervention_name>
    <description>Diazépam drug (0,3 mg/kg) on a single oral intake</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lorazepam</intervention_name>
    <description>Lorazépam drug (0,038 mg/kg) on a single oral intake</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>lorazépam placebo or Diazépam placebo</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects between 18 and 30 years

          -  Students in medicine, dentistry or pharmacy

          -  French as a mother language

        Exclusion criteria:

          -  Medical condition influencing brain function (neurological or psychiatric)

          -  Asthma

          -  General anesthesia in the 3 last months

          -  Drug addiction (DSM IV criteria)

          -  Regular medical treatment (except contraceptive pill)

          -  Significant impairment observed during a medical examination including ECG

          -  Intake of any psychotropic drug that can have a effect during testing

          -  IQ (Wechsler) &lt; 100

          -  FMRI contra-indication (implantable magnetic material, claustrophobia)

          -  Known allergy to benzodiazepine or lactose

          -  &gt; 10 cigarettes/day

          -  Pregnant or breast-feeding woman

          -  No health insurance

          -  Subjects who do not complete the entire study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Vidailhet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux universitaires de strasbourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre d'investigation clinique, hôpital civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique psychiatrique, hôpital civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2008</study_first_submitted>
  <study_first_submitted_qc>June 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2008</study_first_posted>
  <last_update_submitted>September 16, 2009</last_update_submitted>
  <last_update_submitted_qc>September 16, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2009</last_update_posted>
  <responsible_party>
    <name_title>Christine GEILLER, directeur Adjoint</name_title>
    <organization>University Hospital, Strasbourg, France</organization>
  </responsible_party>
  <keyword>Benzodiazepines</keyword>
  <keyword>Lorazepam</keyword>
  <keyword>Diazepam</keyword>
  <keyword>Memory</keyword>
  <keyword>Perceptual priming</keyword>
  <keyword>Functional brain imaging</keyword>
  <keyword>FMRI</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lorazepam</mesh_term>
    <mesh_term>Diazepam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

